IL2 and neoplasm: A tanapoxvirus (TPV) was engineered to express monocyte chemoattractant protein (CCL2) or IL-2 (TPV/D66R/mCCL2 and TPV/D66R/mIL-2) as a safer oncolytic virus with selectivity for tumor cells (96).